IPO registrations (S-1, F-1) · Registrants
Sienna Biopharmaceuticals, Inc.
- SEC CIK
- 1656328 · filings on EDGAR ↗
- Former names
- Sienna Labs, Inc. (2015–2015)
- Registration
- Form S-1, first filed 2017-07-03, last 2017-07-24; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2017-07-27; declared effective 2017-07-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 30699 RUSSELL RANCH ROAD, SUITE 140, Westlake Village, CA 91362
- EIN
- 27-3364627
- EDGAR entity type
- operating
- Insiders and CEO pay
- Sienna Biopharmaceuticals, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2017-07-24)
- Final price
- $15.00 per share, within the range (424B4 filed 2017-07-27, an initial public offering)
- Shares sold
- 4,333,333
- Gross proceeds
- $64,999,995 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SNNA
- Lead underwriters
- J.P. Morgan
- Syndicate
- Cowen; BMO Capital Markets
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: SIENNA BIOPHARMACEUTICALS, INC. EXACT (EIN (EXACT))
- Form D issuer: Sienna Biopharmaceuticals, Inc. EXACT (CIK (EXACT))
- SEC filer: Sienna Biopharmaceuticals, Inc. EXACT (CIK (EXACT))
- Person page: Keith R Leonard Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-07-03 | S-1 | S-1 (registration) | Sienna Biopharmaceuticals, Inc. | 0001193125-17-221074 ↗ |
| 2017-07-17 | S-1/A | S-1/A (amendment) | Sienna Biopharmaceuticals, Inc. | 0001193125-17-228984 ↗ |
| 2017-07-24 | S-1/A | S-1/A (amendment) | Sienna Biopharmaceuticals, Inc. | 0000950123-17-006251 ↗ |
| 2017-07-26 | EFFECT | EFFECT (declared effective) | Sienna Biopharmaceuticals, Inc. | 9999999995-17-001925 ↗ |
| 2017-07-27 | 424B4 | 424B4 (final prospectus) | Sienna Biopharmaceuticals, Inc. | 0001193125-17-238703 ↗ |
| 2018-08-14 | EFFECT | EFFECT (declared effective) | Sienna Biopharmaceuticals, Inc. | 9999999995-18-002100 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-07-24 | S-1/A | registration statement | $14.00–$16.00 | 4,333,333 | - | Nasdaq SNNA | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2017-07-27 | 424B4 | final prospectus | $15.00 | 4,333,333 | $64,999,995 | Nasdaq SNNA | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Andrews Timothy K. | Officer | General Counsel & Secretary | 7 | 2017–2019 | |
| ARCH Venture Fund VIII, L.P. | TenPercentOwner | 3 | 2017–2019 | ||
| ARCH Venture Fund VIII Overage, L.P. | TenPercentOwner | 3 | 2017–2019 | ||
| ARCH Venture Partners VIII, LLC | TenPercentOwner | 4 | 2017–2019 | ||
| ARCH Venture Partners VIII, L.P. | TenPercentOwner | 3 | 2017–2019 | ||
| Beddingfield III Frederick | Director,Officer | President & CEO | 9 | 2017–2019 | |
| Burow Kristina | Director; Director,TenPercentOwner | 6 | 2017–2019 | ||
| BYBEE CLINTON | TenPercentOwner | 3 | 2017–2019 | ||
| CRANDELL KEITH | TenPercentOwner | 4 | 2017–2019 | ||
| FENTON DENNIS M | Director | 4 | 2017–2019 | ||
| Harris Todd | Director; Director,Officer | Head of Corporate Development | 11 | 2017–2019 | |
| Leonard Keith R | Director | 6 | 2017–2019 | person page Fuzzy | |
| Lizzul Paul F. | Officer | Chief Medical Officer | 7 | 2017–2019 | |
| MAST ERLE T | Director | 3 | 2017–2018 | ||
| MORE ROBERT J | Director | 7 | 2017–2019 | ||
| NELSEN ROBERT | Director,TenPercentOwner; TenPercentOwner | 6 | 2017–2019 | ||
| PETERSON RICHARD D | Officer | Chief Financial Officer | 3 | 2017 | |
| Stroehmann Diane | Officer | See Remarks | 6 | 2017–2019 | |
| Smither John W | Officer | Chief Financial Officer | 4 | 2018–2019 | |
| Hindman James M. | Director | 3 | 2018–2019 | ||
| ARCH Venture Fund X Overage, L.P. | TenPercentOwner | 1 | 2019 | ||
| ARCH Venture Partners X, LLC | TenPercentOwner | 1 | 2019 | ||
| ARCH Venture Partners X Overage, L.P. | TenPercentOwner | 1 | 2019 | ||
| GILLIS STEVEN | TenPercentOwner | 1 | 2019 | ||
| Azoy Alexander | Officer | Chief Financial Officer | 5 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-05-15 | Sienna Biopharmaceuticals, Inc. | Biotechnology | $40,500,000 | $40,471,910 | 29 | 1 |
| 2015-10-20 | Sienna Biopharmaceuticals, Inc. | Biotechnology | $50,000,000 | $46,630,453 | 91 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | SIENNA BIOPHARMACEUTICALS, INC. | CA | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | Sienna Biopharmaceuticals, Inc. | CA | Form D private offerings | CIK (EXACT) |
| Patent assignee | Sienna Biopharmaceuticals, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | Sienna Biopharmaceuticals, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Sienna Biopharmaceuticals, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | SIENNA BIOPHARMACEUTICALS, INC. | EIN (EXACT) | ||
| Person page | Keith R Leonard | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
- Regen BioPharma Inc CA
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- Diadexus, Inc. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health